Your weekly roundup of the latest news from Drug Topics®.
The use of drones to deliver critically important therapies can help overcome the barriers to care that impact patients in metropolitan areas.
Cariprazine is already approved to treat schizophrenia and bipolar I in adults.
COVID-19 updates and news to know as of February 21, 2022.
Recent treatment may affect the antibody response, particularly among those with hematologic cancers.
Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.